HighTower Advisors’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.9K | Buy |
2,302
+500
| +28% | +$4.97K | ﹤0.01% | 3553 |
|
|
2025
Q1 | $17.1K | Buy |
1,802
+1,600
| +792% | +$15.2K | ﹤0.01% | 3462 |
|
|
2024
Q4 | $2.79K | Sell |
202
-104
| -34% | -$1.44K | ﹤0.01% | 3484 |
|
|
2024
Q3 | $5K | Sell |
306
-5,995
| -95% | -$98K | ﹤0.01% | 3453 |
|
|
2024
Q2 | $30K | Buy |
6,301
+5,400
| +599% | +$25.7K | ﹤0.01% | 3303 |
|
|
2024
Q1 | $6K | Buy |
+901
| New | +$6K | ﹤0.01% | 3296 |
|
|
2023
Q1 | – | Sell |
-19,885
| Closed | -$76K | – | 3144 |
|
|
2022
Q4 | $76K | Buy |
19,885
+3,001
| +18% | +$11.5K | ﹤0.01% | 2928 |
|
|
2022
Q3 | $102K | Sell |
16,884
-3,599
| -18% | -$21.7K | ﹤0.01% | 2736 |
|
|
2022
Q2 | $72K | Sell |
20,483
-1,400
| -6% | -$4.92K | ﹤0.01% | 2814 |
|
|
2022
Q1 | $75K | Buy |
+21,883
| New | +$75K | ﹤0.01% | 2988 |
|
|
2021
Q4 | – | Sell |
-53,960
| Closed | -$215K | – | 3043 |
|
|
2021
Q3 | $215K | Buy |
53,960
+47,660
| +757% | +$190K | ﹤0.01% | 2639 |
|
|
2021
Q2 | $33K | Sell |
6,300
-6,000
| -49% | -$31.4K | ﹤0.01% | 2862 |
|
|
2021
Q1 | $57K | Sell |
12,300
-4,000
| -25% | -$18.5K | ﹤0.01% | 2771 |
|
|
2020
Q4 | $56K | Buy |
16,300
+6,000
| +58% | +$20.6K | ﹤0.01% | 2326 |
|
|
2020
Q3 | $55K | Sell |
10,300
-2,700
| -21% | -$14.4K | ﹤0.01% | 2251 |
|
|
2020
Q2 | $59K | Buy |
+13,000
| New | +$59K | ﹤0.01% | 2144 |
|